<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Cork DP</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> The impact of significant tricuspid regurgitation (sTR) on healthcare costs and utilization in real-world populations remains understudied. &lt;b>Aim:&lt;/b> Describe healthcare costs and utilization before and after development of sTR and describe differences by patient demographic characteristics. &lt;b>Materials &amp; methods:&lt;/b> We conducted a retrospective, longitudinal descriptive study using a large database containing electronic health record and insurance claims data for US patients. Healthcare costs and utilization are summarized for up to 3 years prior to sTR and for 1 year after sTR. &lt;b>Results:&lt;/b> Costs and utilization increased in the 3 years leading up to and the year after sTR. Costs were higher for patients who were: aged 50-79 years, male, and Black or Hispanic (p</pubmed_abstract><journal>Journal of comparative effectiveness research</journal><pagination>e250146</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12711070</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Healthcare cost and utilization before and after the development of significant tricuspid regurgitation by age, sex and race.</pubmed_title><pmcid>PMC12711070</pmcid><pubmed_authors>Cork DP</pubmed_authors><pubmed_authors>Kemp L</pubmed_authors><pubmed_authors>Gaba P</pubmed_authors><pubmed_authors>Murphy SM</pubmed_authors><pubmed_authors>Mollenkopf S</pubmed_authors><pubmed_authors>Yeh RW</pubmed_authors><pubmed_authors>Medina F</pubmed_authors><pubmed_authors>Dratch A</pubmed_authors><pubmed_authors>Horn R</pubmed_authors><pubmed_authors>Barker C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Healthcare cost and utilization before and after the development of significant tricuspid regurgitation by age, sex and race.</name><description>&lt;b>Background:&lt;/b> The impact of significant tricuspid regurgitation (sTR) on healthcare costs and utilization in real-world populations remains understudied. &lt;b>Aim:&lt;/b> Describe healthcare costs and utilization before and after development of sTR and describe differences by patient demographic characteristics. &lt;b>Materials &amp; methods:&lt;/b> We conducted a retrospective, longitudinal descriptive study using a large database containing electronic health record and insurance claims data for US patients. Healthcare costs and utilization are summarized for up to 3 years prior to sTR and for 1 year after sTR. &lt;b>Results:&lt;/b> Costs and utilization increased in the 3 years leading up to and the year after sTR. Costs were higher for patients who were: aged 50-79 years, male, and Black or Hispanic (p</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T03:56:47.811Z</modification><creation>2026-05-25T03:12:04.552Z</creation></dates><accession>S-EPMC12711070</accession><cross_references><pubmed>41378753</pubmed><doi>10.57264/cer-2025-0146</doi></cross_references></HashMap>